ArticleTheranostics2015

PEGylated exendin-4, a modified GLP-1 analog exhibits more potent cardioprotection than its unmodified parent molecule on a dose to dose basis in a murine model of myocardial infarction.

Zhongchan Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.